000			01228 a2200373 4500
005			20250515100327.0
264		0	_c20080410
008			200804s 0 0 eng d
022			_a0392-856X
040			_aNLM _beng _cNLM
100	1		_aManadan, A M
245	0	0	_aEtanercept therapy in patients with a positive tuberculin skin test. _h[electronic resource]
260			_bClinical and experimental rheumatology _c
300			_a743-5 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntirheumatic Agents _xadverse effects
650	0	4	_aEtanercept
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xadverse effects
650	0	4	_aMale
650	0	4	_aReceptors, Tumor Necrosis Factor _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aRheumatic Diseases _xdrug therapy
650	0	4	_aRisk Factors
650	0	4	_aTuberculin Test
650	0	4	_aTuberculosis _xchemically induced
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
700	1		_aJoyce, K
700	1		_aSequeira, W
700	1		_aBlock, J A
773	0		_tClinical and experimental rheumatology _gvol. 25 _gno. 5 _gp. 743-5
999			_c17591875 _d17591875